TrialBritish journal of haematology2012

Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE).

Lori Styles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.